Cargando…
Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study
BACKGROUND: The aim was to investigate psychotropic medication use in parents of survivors of adolescent cancer from the acute post‐diagnostic phase and up to 2 years following the cancer diagnosis. METHODS: This study had a nationwide register‐based cohort design comparing psychotropic medication u...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678086/ https://www.ncbi.nlm.nih.gov/pubmed/35474312 http://dx.doi.org/10.1002/cam4.4780 |
_version_ | 1784833917536174080 |
---|---|
author | Wikman, Anna Hovén, Emma Alvariza, Anette Lövgren, Malin Kreicbergs, Ulrika Skoglund, Charlotte Fransson, Emma Ljungman, Gustaf Ljung, Rickard Ljungman, Lisa |
author_facet | Wikman, Anna Hovén, Emma Alvariza, Anette Lövgren, Malin Kreicbergs, Ulrika Skoglund, Charlotte Fransson, Emma Ljungman, Gustaf Ljung, Rickard Ljungman, Lisa |
author_sort | Wikman, Anna |
collection | PubMed |
description | BACKGROUND: The aim was to investigate psychotropic medication use in parents of survivors of adolescent cancer from the acute post‐diagnostic phase and up to 2 years following the cancer diagnosis. METHODS: This study had a nationwide register‐based cohort design comparing psychotropic medication use in parents of adolescent survivors of cancer (n = 2323) to use in parents of cancer‐free controls (n = 20,868). Cox proportional hazards models, adjusted for cancer diagnostic group, parents' age, country of birth, education level, marital status and previous mental health problems estimated the risk of use from the time of the cancer diagnosis up to 2 years later. RESULTS: During the first 6 months after the cancer diagnosis, both mothers and fathers had an increased risk of use of anxiolytics (mothers: HR(adj) 1.71, 95% CI 1.30–2.25; fathers: HR(adj) 1.57, 95% CI 1.10–2.45) and hypnotics/sedatives (mothers: HR(adj) 1.53, 95% CI 1.23–1.90; fathers: HR(adj) 1.32, 95% CI 1.00–1.75). For fathers with a prescription of psychotropic medication during the first 6 months after the cancer diagnosis, the risk remained increased after 6 months (HR(adj) 1.66, 95% CI 1.04–2.65). From 6 months after the cancer diagnosis, only the risk of antidepressant use among mothers was increased (HR(adj) 1.38, 95% CI 1.08–1.76). Risk factors included being divorced/widowed, born in a non‐Nordic country, older age and having had previous mental health problems. CONCLUSION: Our study results show that during the immediate post‐diagnostic phase, mothers and fathers of survivors of adolescent cancer are at increased risk of use of anxiolytics and sedatives, whereas only mothers are at increased risk of antidepressant use from 6 months until 2 years after the diagnosis. Further, previous mental health problems were shown to be the strongest risk factor for psychotropic medication use in both mothers and fathers, pointing to the particular vulnerability of these parents. |
format | Online Article Text |
id | pubmed-9678086 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96780862022-11-22 Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study Wikman, Anna Hovén, Emma Alvariza, Anette Lövgren, Malin Kreicbergs, Ulrika Skoglund, Charlotte Fransson, Emma Ljungman, Gustaf Ljung, Rickard Ljungman, Lisa Cancer Med Research Articles BACKGROUND: The aim was to investigate psychotropic medication use in parents of survivors of adolescent cancer from the acute post‐diagnostic phase and up to 2 years following the cancer diagnosis. METHODS: This study had a nationwide register‐based cohort design comparing psychotropic medication use in parents of adolescent survivors of cancer (n = 2323) to use in parents of cancer‐free controls (n = 20,868). Cox proportional hazards models, adjusted for cancer diagnostic group, parents' age, country of birth, education level, marital status and previous mental health problems estimated the risk of use from the time of the cancer diagnosis up to 2 years later. RESULTS: During the first 6 months after the cancer diagnosis, both mothers and fathers had an increased risk of use of anxiolytics (mothers: HR(adj) 1.71, 95% CI 1.30–2.25; fathers: HR(adj) 1.57, 95% CI 1.10–2.45) and hypnotics/sedatives (mothers: HR(adj) 1.53, 95% CI 1.23–1.90; fathers: HR(adj) 1.32, 95% CI 1.00–1.75). For fathers with a prescription of psychotropic medication during the first 6 months after the cancer diagnosis, the risk remained increased after 6 months (HR(adj) 1.66, 95% CI 1.04–2.65). From 6 months after the cancer diagnosis, only the risk of antidepressant use among mothers was increased (HR(adj) 1.38, 95% CI 1.08–1.76). Risk factors included being divorced/widowed, born in a non‐Nordic country, older age and having had previous mental health problems. CONCLUSION: Our study results show that during the immediate post‐diagnostic phase, mothers and fathers of survivors of adolescent cancer are at increased risk of use of anxiolytics and sedatives, whereas only mothers are at increased risk of antidepressant use from 6 months until 2 years after the diagnosis. Further, previous mental health problems were shown to be the strongest risk factor for psychotropic medication use in both mothers and fathers, pointing to the particular vulnerability of these parents. John Wiley and Sons Inc. 2022-04-26 /pmc/articles/PMC9678086/ /pubmed/35474312 http://dx.doi.org/10.1002/cam4.4780 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Wikman, Anna Hovén, Emma Alvariza, Anette Lövgren, Malin Kreicbergs, Ulrika Skoglund, Charlotte Fransson, Emma Ljungman, Gustaf Ljung, Rickard Ljungman, Lisa Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study |
title | Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study |
title_full | Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study |
title_fullStr | Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study |
title_full_unstemmed | Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study |
title_short | Psychotropic medication use in parents of survivors of adolescent cancer: A register‐based cohort study |
title_sort | psychotropic medication use in parents of survivors of adolescent cancer: a register‐based cohort study |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678086/ https://www.ncbi.nlm.nih.gov/pubmed/35474312 http://dx.doi.org/10.1002/cam4.4780 |
work_keys_str_mv | AT wikmananna psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy AT hovenemma psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy AT alvarizaanette psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy AT lovgrenmalin psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy AT kreicbergsulrika psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy AT skoglundcharlotte psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy AT franssonemma psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy AT ljungmangustaf psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy AT ljungrickard psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy AT ljungmanlisa psychotropicmedicationuseinparentsofsurvivorsofadolescentcanceraregisterbasedcohortstudy |